Onapgo® (apomorphine hydrochloride)
for Parkinson’s Disease
Onapgo (apomorphine hydrochloride), a dopamine agonist, is a wearable infusion device used to relieve motor fluctuations in adults with advanced Parkinson's disease. It provides a continuous infusion of apomorphine under the skin to manage "off" episodes, improving mobility. Onapgo acts on dopamine receptors in the brain, mimicking dopamine's effects. By stimulating D2-type dopamine receptors, it helps alleviate motor symptoms such as tremors, rigidity, and bradykinesia.
